Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 27 (12), 1265-1270
- https://doi.org/10.1016/0028-3908(88)90029-9
Abstract
No abstract availableFunding Information
- Wellcome Trust
This publication has 21 references indexed in Scilit:
- Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxideNeuropharmacology, 1988
- The hypothermic response of mice to delta-9-tetrahydrocannabinol is enhanced by chlorpromazine, thioxanthenes, alpha-adrenoceptor antagonists and pentolinium but not by SCH 23390 or sulpirideNeuropharmacology, 1988
- Baclofen induces catatonia in ratsNeuropharmacology, 1987
- GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: Differences between dorsal and ventral striatumBrain Research, 1984
- Unusual interactions of benzodiazepine receptor antagonistsNature, 1982
- Baclofen: 10 years onTrends in Pharmacological Sciences, 1982
- GABA‐like Actions of LevonantradolThe Journal of Clinical Pharmacology, 1981
- Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitroLife Sciences, 1981
- Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitroLife Sciences, 1978
- Cholinergic- and neuroleptic-induced catalepsy: Modification by lesions in the caudate-putamenNeuropharmacology, 1971